ArticlePreventive medicine reports2026
Triangulating youth tobacco use and product appeal for rapid surveillance: Findings from three online surveys.
Article in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Accelerating tobacco regulatory science in the United States: The center for rapid surveillance of tobacco.Preventive medicine reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Objective: Understanding youth tobacco use is essential to informing timely regulatory and public health responses. Triangulating traditional nationally representative survey results with more rapid and flexible survey data can provide important interim surveillance opportunities to confirm prevalence trends and timely opportunities to respond to observed changes. Methods: This paper reports on the generation of rapid surveillance data on youth tobacco use by triangulating three exemplar online survey data sources: two U.S. nationally representative Ipsos surveys (Ipsos-1: Results: Findings demonstrate consistency across surveys, with e-cigarettes being the most prevalent product among youth (5.6-14.6 %), while other product use was low, including nicotine pouches (1.3-2.6 %). Popular brands (e.g., Geek Bar®, Juul®), appeal of e-cigarette characteristics (e.g., ability to use discreetly), and perceptions of colorful devices (e.g., less harsh, better tasting) versus plain/black/Gy devices were recurrent themes, suggesting that rapid surveillance can effectively identify and monitor trends in real time. Conclusions: These insights underscore the need for continued agile surveillance systems and tailored regulatory strategies focused on youth-attractive e-cigarette features.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.